Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.
2.

Physical activity in youth with osteogenesis imperfecta type I.

Pouliot-Laforte A, Veilleux LN, Rauch F, Lemay M.

J Musculoskelet Neuronal Interact. 2015 Jun;15(2):171-6.

3.

Muscle anatomy and dynamic muscle function in osteogenesis imperfecta type I.

Veilleux LN, Lemay M, Pouliot-Laforte A, Cheung MS, Glorieux FH, Rauch F.

J Clin Endocrinol Metab. 2014 Feb;99(2):E356-62. doi: 10.1210/jc.2013-3209. Epub 2013 Nov 18.

PMID:
24248189
4.

The functional muscle-bone unit in patients with osteogenesis imperfecta type I.

Veilleux LN, Pouliot-Laforte A, Lemay M, Cheung MS, Glorieux FH, Rauch F.

Bone. 2015 Oct;79:52-7. doi: 10.1016/j.bone.2015.05.019. Epub 2015 May 21.

PMID:
26004918
5.

Agreement between vertical ground reaction force and ground reaction force vector in five common clinical tests.

Veilleux LN, Rauch F, Lemay M, Ballaz L.

J Musculoskelet Neuronal Interact. 2012 Dec;12(4):219-23.

6.

Osteogenesis imperfecta in childhood: impairment and disability.

Engelbert RH, van der Graaf Y, van Empelen R, Beemer FA, Helders PJ.

Pediatrics. 1997 Feb;99(2):E3.

PMID:
9099760
7.

Analysing gait using a force-measuring walkway: intrasession repeatability in healthy children and adolescents.

Veilleux LN, Ballaz L, Robert M, Lemay M, Rauch F.

Comput Methods Biomech Biomed Engin. 2014;17(13):1447-51. doi: 10.1080/10255842.2012.751984. Epub 2013 Jan 29.

PMID:
23360226
8.

Results of a prospective pilot trial on mobility after whole body vibration in children and adolescents with osteogenesis imperfecta.

Semler O, Fricke O, Vezyroglou K, Stark C, Stabrey A, Schoenau E.

Clin Rehabil. 2008 May;22(5):387-94. doi: 10.1177/0269215507080763.

PMID:
18441035
9.

Ankle strength and functional limitations in children and adolescents with type I osteogenesis imperfecta.

Caudill A, Flanagan A, Hassani S, Graf A, Bajorunaite R, Harris G, Smith P.

Pediatr Phys Ther. 2010 Fall;22(3):288-95. doi: 10.1097/PEP.0b013e3181ea8b8d.

PMID:
20699778
10.

Osteogenesis imperfecta in childhood: perceived competence in relation to impairment and disability.

Engelbert RH, Gulmans VA, Uiterwaal CS, Helders PJ.

Arch Phys Med Rehabil. 2001 Jul;82(7):943-8.

PMID:
11441383
11.

Bone mineral density in developing children with osteogenesis imperfecta: a longitudinal study with 9 years of follow-up.

Kok DH, Sakkers RJ, Pruijs HE, Joosse P, Castelein RM.

Acta Orthop. 2013 Aug;84(4):431-6. doi: 10.3109/17453674.2013.831321.

12.

Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.

Land C, Rauch F, Travers R, Glorieux FH.

Bone. 2007 Mar;40(3):638-44. Epub 2006 Nov 28.

PMID:
17127117
13.

Muscle strength, joint range of motion, and gait in children and adolescents with osteogenesis imperfecta.

Brizola E, Staub AL, FĂ©lix TM.

Pediatr Phys Ther. 2014 Summer;26(2):245-52. doi: 10.1097/PEP.0000000000000042.

PMID:
24675130
14.

Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.

Bradbury LA, Barlow S, Geoghegan F, Hannon RA, Stuckey SL, Wass JA, Russell RG, Brown MA, Duncan EL.

Osteoporos Int. 2012 Jan;23(1):285-94. doi: 10.1007/s00198-011-1658-2. Epub 2011 Jul 8.

PMID:
21739105
15.

Central corneal thickness is lower in osteogenesis imperfecta and negatively correlates with the presence of blue sclera.

Evereklioglu C, Madenci E, Bayazit YA, Yilmaz K, Balat A, Bekir NA.

Ophthalmic Physiol Opt. 2002 Nov;22(6):511-5.

PMID:
12477015
16.

Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations.

Roschger P, Fratzl-Zelman N, Misof BM, Glorieux FH, Klaushofer K, Rauch F.

Calcif Tissue Int. 2008 Apr;82(4):263-70. doi: 10.1007/s00223-008-9113-x. Epub 2008 Mar 3.

PMID:
18311573
18.

Differing lumbar vertebral mineralization rates in ambulatory pediatric patients with osteogenesis imperfecta.

Reinus WR, McAlister WH, Schranck F, Chines A, Whyte MP.

Calcif Tissue Int. 1998 Jan;62(1):17-20.

PMID:
9405727
19.

Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta.

Montpetit K, Plotkin H, Rauch F, Bilodeau N, Cloutier S, Rabzel M, Glorieux FH.

Pediatrics. 2003 May;111(5 Pt 1):e601-3.

PMID:
12728117
20.

The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.

Zeitlin L, Rauch F, Travers R, Munns C, Glorieux FH.

Bone. 2006 Jan;38(1):13-20. Epub 2005 Sep 12.

PMID:
16162424

Supplemental Content

Support Center